$10.35
▲ +$0.34
(+3.40%)
Vol 440K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.4B
ROE
-23.3%
Margin
-136.7%
D/E
3.93
Beta
1.35
52W
$3–$12
Wall Street Consensus
17 analysts · Apr 20267
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
94.1%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-0.40
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.40 | — | — |
| Dec 2025 | $-0.38 | $-0.29 | +$0.09 |
| Sep 2025 | $-0.40 | $-0.42 | $-0.02 |
| Jun 2025 | $-0.33 | $-0.58 | $-0.25 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $56.3M | $18.6M | $4.7M | $5.2M | $19.8M |
| Net Income | — | $44.9M | -$39.9M | -$70.3M | -$50.5M | -$35.7M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -15.1% | -4.6% | -15.1% | -15.1% | -23.3% | -23.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1485.1% | -15.0% | -56.8% | -56.8% | -136.7% | -136.7% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 3.68 | 3.43 | 3.68 | 3.68 | 3.93 | 3.93 |
| Current Ratio | 8.80 | 10.28 | 8.80 | 8.80 | 7.36 | 7.36 |
Key Ratios
ROA (TTM)
-19.1%
P/S (TTM)
14.14
P/B
1.3
EPS (TTM)
$-0.96
CF/Share
$-1.06
Rev Growth 3Y
+64.8%
52W High
$12.41
52W Low
$3.30
$3.30
52-Week Range
$12.41
Financial Health
Free Cash Flow
-$59.7M
Net Debt
-$330.3M
Cash
$345.9M
Total Debt
$15.6M
As of Dec 31, 2025
How does IMTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
IMTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
14.1
▲
10%
above
peers
(12.9)
vs Peers
vs Industry
Fair value
P/B ratio
1.3
▼
49%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
IMTX profitability vs Biotechnology peers
ROE
-23.3%
▲
65%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-136.7%
▲
52%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-19.1%
▲
59%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
IMTX financial health vs Biotechnology peers
D/E ratio
3.9
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
7.4
▲
66%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.4
▲
39%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
IMTX fundamentals radar
IMTX
Peer median
Industry
IMTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IMTX vs peers: key metrics
Top Holders
Top 5: 49.63%T. Rowe Price Investment Ma…
16.00%
$201.0M
Baker Bros. Advisors, LP
9.02%
$113.3M
RTW Investments LP
8.53%
$107.1M
Suvretta Capital Management…
8.34%
$104.8M
Perceptive Advisors Llc
7.74%
$97.2M
As of Dec 31, 2025
Latest News
No related news yet